Friday, 28 February 2014

Bevacizumab Does Not Offer Survival Benefits in Newly Diagnosed Glioblastoma Patients

A new study has found that the drug bevacizumab offers no survival benefits for patients with newly diagnosed glioblastoma or brain tumor. "The results of this study are counter to most expectations," said Dr. Brachman, Director of Radiation Oncology at Barrow and St. Joseph's. "Bevacizumab had been shown in earlier studies to be an effective drug in the treatment of patients with recurrent disease. But, on newly diagnosed patients, it did not, in fact, prolong ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1bTZv3G

Former Slave Trade Town on the Way to Becoming Art Hub in Africa

The Gateway of No Return was the only attraction for the few tourists who visited the small west African town of Ouidah until last year. The former is a massive monument to the area's bleak history as a slave trading hub. But the town may soon become known for an attraction of an entirely different sort: the first sub-Saharan Africa museum dedicated exclusively to contemporary African art. The Zinsou Museum, installed in an ornate 100-year-old villa, ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1eJxTcc

REGiMMUNE's Transplant Tolerance Results Reported in American Journal of Transplantation

A paper that describes a novel approach to long-term tolerance in organ transplantation with continuous administration of immune suppressants has been published by the iAmerican Journal of Transplantation/i (iAJT/i), REGiMMUNE Corporation has announced. "A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells with Costimulatory Blockade" was published in the iAJT/i March 2014 Issue 3, Volume 14, pages 554-567, and ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1hsxaBq

3-D Structure of Enzyme That Protects the Body from Bacteria Discovered

An important weapon that plays a role in the body's fight against infection has come into a clearer view. Researchers at Princeton University have discovered the 3D structure of an enzyme that cuts to ribbons the genetic material of viruses and helps defend against bacteria. The discovery of the structure of this enzyme, a first-responder in the body's "innate immune system," could enable new strategies for fighting infectious agents and possibly prostate cancer ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1fxBx9o

Asthma Drug may Desensitize Several Food Allergies

A new study has found how an asthma drug could accelerate the process of desensitizing patients having different food allergies at the same time!. The findings come on the heels of a recent study by the same team showing that people with multiple food allergies can be desensitized to several foods at once. The two studies, both phase-1 safety trials, provide the first scientific evidence that a promising new method for treating people for multiple food allergies ...




via Medindia Health News More READ


Lake forest health and fitness http://ift.tt/1fxBuub